Financials

Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
26.26
Price to sales ratio
4.55

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
124
SYK
Stryker Corporation Common Stock
316.37 USD+1.65%-2.45%+3.05%-18.87%121.28 B USD
149
MDT
Medtronic plc. Ordinary Shares
80.50 USD+1.50%-1.44%-0.68%-14.21%103.04 B USD
306
MDLN
Medline Inc. - Class A common stock
39.44 USD+2.02%-2.13%+6.77%+12.69%51.81 B USD
313
EW
Edwards Lifesciences Corporation Common Stock
87.27 USD-3.13%-6.21%-0.55%+14.30%50.25 B USD

Frequently asked questions about Boston Scientific Corporation Common Stock

What is the Boston Scientific Corporation Common Stock stock price today?

The current price of Boston Scientific Corporation Common Stock (BSX) is 43.07. Over the past 24 hours, the stock has changed by +1.03%. Follow the BSX chart for real-time price dynamics.

What is the stock ticker of Boston Scientific Corporation Common Stock?

Boston Scientific Corporation Common Stock trades under the ticker BSX. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Boston Scientific Corporation Common Stock stock going up?

BSX has changed by -3.45% over the last week, -7.10% over the last month, and -58.14% over the last year. Review the chart to see whether the current move is part of a broader trend.

What was Boston Scientific Corporation Common Stock net income for the last quarter?

Boston Scientific Corporation Common Stock reported net income of 1.34 B for the last quarter. The previous quarter showed 670 M, which means net income changed by +99.85%.

How many employees does Boston Scientific Corporation Common Stock have?

As of the latest available data, Boston Scientific Corporation Common Stock has 59 K employees. Workforce size can provide additional context about the company's scale and operations.

What is Boston Scientific Corporation Common Stock EBITDA?

Boston Scientific Corporation Common Stock EBITDA is 1.45 B, and its EBITDA margin is 27.89%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy Boston Scientific Corporation Common Stock stock?

You can buy Boston Scientific Corporation Common Stock (BSX) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Boston Scientific Corporation Common Stock stock?

Investing in Boston Scientific Corporation Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the BSX chart and related analysis on metatrader.com as part of your research.

Boston Scientific Corporation Common Stock

Boston Scientific Corporation is an American biotechnology and biomedical engineering firm and multinational manufacturer of medical devices used in interventional medical specialties, including interventional radiology, interventional cardiology, peripheral interventions, neuromodulation, neurovascular intervention, electrophysiology, cardiac surgery, vascular surgery, endoscopy, oncology, urology and gynecology. The company is known for the development of the Taxus Stent, a drug-eluting stent which is used to open clogged arteries. The company acquired Cameron Health in June 2012 and began to offer a minimally invasive implantable cardioverter-defibrillator called the EMBLEM subcutaneous implantable defibrillator. Over the last 20 years, Boston Scientific has had some high-profile patent infringement cases. It has made extensive payouts, including $1.725 billion to Johnson & Johnson, $85 million to Nevro and $42 million to TissueGen. BSC is headquartered in Marlborough, Massachusetts and incorporated in Delaware.

News